Delivery Order SPE2DX22D0079-SPE2D826FAAY3
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,257.39 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order is being performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,140.36 to AmerisourceBergen Drug Corp on November 17, 2025, with completion targeted for November 18, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order was issued to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,938.16 to AmerisourceBergen Drug Corp on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The delivery order was placed to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $25,740.22 to AmerisourceBergen Drug Corp on December 8, 2025, with completion expected by December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,651.86 to AmerisourceBergen Drug Corp on June 23, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The delivery order will be fulfilled from the vendor's Corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $24,106.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $58,117.57 to AmerisourceBergen Drug Corp on November 24, 2025, with completion expected by November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order was placed with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $44,402.40 to AmerisourceBergen Drug Corp on November 11, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The delivery order will be performed at...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FAAY3Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,160.92 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order was placed with AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, where the performance will also take place. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company maintains a $999.99 billion IDC with DLA Troop Support Medical through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order exemplifies the company's ongoing role as a key vendor supporting Defense Health Agency procurement and other federal healthcare systems through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/7/25 |